Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02772731 · ClinicalTrials.gov registry record · NA
Shave Margins vs. Standard Partial Mastectomy in Breast Cancer Patients
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
NCT02772731 is a NA study that has completed, run by Yale University. The registered enrollment target is 400 participants.
The verdict
NCT02772731, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
Study Summary
Breast cancer is the most common malignancy affecting women in the US. Surgical management is the mainstay of therapy, and in general consists of resection of the primary tumor with either a partial mastectomy (aka "lumpectomy") or a total mastectomy. The investigators hypothesize that routine shave margins during partial mastectomy will significantly reduce positive margin rate. A positive margin means that cancerous cells were detected at the edge of the excised area. This generally mandates a return to the operating room for re-excision.
Interventions
- PROCEDURE Partial mastectomy
- PROCEDURE Partial mastectomy plus additional Shave Margin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2016-07 |
| Est. Completion | 2024-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02772731
The ClinicalTrials.gov registry entry for NCT02772731 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Partial mastectomy is the first listed.
NCT02772731 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02772731 about?
NCT02772731 is a clinical study titled "Shave Margins vs. Standard Partial Mastectomy in Breast Cancer Patients". Breast cancer is the most common malignancy affecting women in the US. Surgical management is the mainstay of therapy, and in general consists of resection of the primary tumor with either a partial mastectomy (aka "lumpectomy") or a total mastectomy. The investigators hypothesize that routine shav...
What is the current status of trial NCT02772731?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2016-07. Estimated completion is 2024-11.
What interventions are being tested in trial NCT02772731?
The interventions under investigation include: Partial mastectomy (PROCEDURE), Partial mastectomy plus additional Shave Margin (PROCEDURE).
Who is sponsoring clinical trial NCT02772731?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.